BioWorld MedTech

Dec. 31, 2014

CytoSorbents seeks IDE for intra-operative use of CytoSorb treatment

A device designed to be installed into a heart-lung machine and used intra-operatively during complex cardiac surgery in an effort to reduce post-operative complications may soon be making its way through the U.S. regulatory process. Read More

Six leading research centers launch Cancer Core Europe

Alpinion Medical Systems rolls out South Korea's first HIFU

Kalorama identifies top trends that impacted med-tech in 2014

Abbott sheds light on early results for tender offer

Heart Sync electrode latest in slew of recalls related to Philips AEDs

Briefly Noted

Modernizing Medicine completes acquisition of Aesyntix Health

Keeping you up to date on recent events with Oncology

Today's news in brief

BioWorld

BioWorld briefs for Nov. 25, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 25, 2024.

J&J’s Ottava robotic system approved for US pivotal trial

BioWorld MedTech

Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...